1,439 results on '"Sanofi S.A. -- Forecasts and trends"'
Search Results
2. Q2 2024 Sanofi SA Earnings Call - Final
3. Antiplatelet Market Analysis Report 2024, Featuring Profiles of AstraZeneca, Sanofi, Daiichi Sankyo, Bayer, Torrent Pharmaceuticals, Lupin, Cipla, Baxter, Takeda and Glenmark Pharmaceuticals - ResearchAndMarkets.com
4. Bronchiectasis Market Size in the 7MM was ~USD 1,581.2 million in 2023, estimated DelveInsight
5. Antiplatelet Market Analysis Report 2024, Featuring Profiles of AstraZeneca, Sanofi, Daiichi Sankyo, Bayer, Torrent Pharmaceuticals, Lupin, Cipla, Baxter, Takeda and Glenmark Pharmaceuticals
6. Male Infertility Global Strategic Business Report 2024-2030 with Focus on 30+ Key Players Including Andrology Solutions, Bayer, Cadila, Endo, Halotech DNA, Intas, Merck, Sanofi, SCSA, * Vitrolife
7. Chronic Obstructive Pulmonary Disease Market Size was valued at USD 16,075 million in 2023, estimated DelveInsight
8. Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
9. Rare Hematology Market to Grow by USD 4.58 Billion (2024-2028) as Strategic Portfolio Enhancements Drive Revenue; AI's Impact on Market Trends Report - Technavio
10. Anti-CD38 mAb Market to Accelerate Substantially During the Study Period (2020-2034) Owing to a Strong Uptake of DARZALEX in Multiple Myeloma and Expected Entry of anti-CD38 mAbs in Autoimmune Diseases | DelveInsight
11. Acute Myocardial Infarction Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Regeneron, Sanofi, Amgen, Boehringer Ingelheim, Eli Lilly and Company, Faraday Pharma
12. Press Release: Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcare
13. Hematopoietic Stem Cell Transplantation Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Sanofi, Actinium Pharma, Medexus Pharma, medac Pharma, Actinium Pharma
14. Global Cancer Therapy Market Size to grow at a CAGR of ~9% by 2030, Evaluates DelveInsight
15. GLP-1 Analogues Market worth $471.1 billion by 2032 | MarketsandMarkets™
16. Chronic Urticaria Competitive Landscape Assessment 2024: Regeneron|Sanofi (Dupixent) and Genentech|Novartis (Xolair) Dominate the Market
17. Chronic Spontaneous Urticaria Treatment Market Size in the 7MM was ~USD 2200 Million in 2023, estimated DelveInsight
18. Japan Knee Hyaluronic Acid Injections Market to Worth Over USD 260.41 Million By 2032
19. $12.5 Bn Influenza Vaccine Market to 2032 by Vaccine Type, Technology, Age Group, Route of Administration, and Region
20. Q1 2024 Innate Pharma SA Corporate Sales Call - Final
21. Q4 2023 Innate Pharma SA Earnings Call - Final
22. LATEST COMPANY NEWS
23. Global Anti-Infective Drugs Market is Projected to Cross ~USD 175 Billion by 2030 | DelveInsight
24. Insomnia Drugs Business Research Report 2023-2030 Featuring Astellas Pharma, Eisai, Flynn Pharma, Johnson & Johnson, Meda, Merck, Pfizer, Sanofi, and Takeda
25. Self-Monitoring Blood Glucose Device Market Report and Company Analysis 2024-2032 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, Novo Nordisk
26. Achondroplasia Market is Expected to Show a Significant Growth During the Forecast Period | Pfizer, Sanofi, ProLynx, PhaseBio, Ascendis, BioMarin
27. GLP-1 Analogues Market Forecast: USD 471.1 Billion by 2032 with a 33.2% CAGR | MarketsandMarkets™
28. U.S. Pediatric Supplements Market Insights 2024-2029 Featuring Key Vendors - Abbott, Amway, Haleon, Bayer, Reckitt Benckiser, Nestle, Sanofi-aventis, Unilever, THG, H&H
29. Coagulation Factor Deficiency Market - US to Have the Lion's Share Among the 7MM's | DelveInsight
30. Global Recombinant Proteins Industry Research 2023-2024 & 2029 Featuring Prominent Players - Amgen, Bayer, F. Hoffmann-La Roche, Lilly, Merck, Novo Nordisk, Pfizer, Sandoz Group, Sanofi, Takeda
31. Biologics Market to Register Growth at a Significant CAGR, DelveInsight | Gsk, Eli Lilly, Roche, Abbvie, Amgen, Sanofi, Merck, Novartis, Pfizer, Astrazeneca
32. JAK Inhibitor Market to Grow at a decent CAGR during the Study Period (2020-2034) by DelveInsight | Eli Lilly, Incyte, Dompe Farmaceutici S.p.A, Sanofi, Celgene, AstraZeneca, Karyopharm Therapeutics
33. Achondroplasia Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Ribomic Inc, Sanofi, Changchun GeneScience Pharma, QED
34. Acanthamoeba Keratitis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight
35. Sanofi price target raised to EUR 117 from EUR 111 at Guggenheim
36. Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis
37. Multiple Sclerosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis AG, Sanofi, F. Hoffmann-La Roche, Celgene Crp., Johnson & Johnson
38. Respiratory Syncytial Virus Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | GlaxoSmithKline, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV
39. Clear Cell Carcinoma Market to Show a Rise During the Forecast Period | F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc
40. Severe Asthma Market Forecast by 2032: Epidemiology Analysis, Emerging Therapies, Regulatory Updates by DelveInsight | Sanofi, GlaxoSmithKline, EMS, Oneness Biotech, Incyte Crp, CSPC ZhongQi Pharma
41. Warm Autoimmune Hemolytic Anemia Market to Observe Significant Growth During the Forecast Period | Rigel Pharmaceuticals, Apellis Pharmaceuticals, Inc., Johnson & Johnson, Sanofi, Incyte Corporation
42. DelveInsight predicts significant growth in the global liver disease treatment market by 2030, with major companies like AbbVie, GSK, Roche, Bristol-Myers Squibb, Abbott, Gilead Sciences, and Astellas Pharma leading the way
43. Metastatic Colorectal Cancer Pipeline 2024 | Pfizer, Sanofi, Taiho Pharma, Ono Pharma, Hutchison Medipharma, Isofol Medical, Sumitomo Dainippon Pharma, G1 Therapeutics, Merck, AB Science
44. Multiple Myeloma Market size was USD 21,300 million in 2023, estimates DelveInsight | GlaxoSmithKline, Bristol-Myers Squibb, Bluebird bio, Oncopeptides AB, Secura Bio, Amgen, Takeda, Pfizer, more
45. Rheumatoid Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examines DelveInsight | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH
46. MULTIPLE SCLEROSIS MARKET OUTLOOK 2032 | Immune Response BioPharma Inc., Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, TG Therapeutics, Inc., Apimeds Inc., Bayer HealthCare, Novartis, Biogen, Alk
47. Hemophilia B Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharmaceuticals, CSL Behring, uniQure
48. Metastatic Non-Small Cell Lung Cancer Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA
49. Juvenile Idiopathic Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examines DelveInsight | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB Pharma
50. Chronic Obstructive Pulmonary Disease Market Size in the 7MM is expected to grow by 2032 | DelveInsight
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.